Latest Institutional Placement News

CurveBeam AI’s FY2026 results show a 28% revenue decline and a 12% increase in net loss, while advancing its China commercialisation and robotic surgery integration strategies. The company also announced a $6-7 million capital raise post-year-end.

Vection Technologies (ASX:VR1) achieved a major earnings inflection in FY26 with adjusted EBITDA soaring 596% to $3.8 million and generating positive operating cash flow for the first time, underpinned by dual commercial platforms scaling rapidly.

BluGlass Limited reported a 5% reduction in its net loss to A$10.39 million for FY26 despite a 10% revenue dip, boosted by new US defence and industry contracts and a significant capital raise to fund growth.

Paradigm Biopharmaceuticals has surpassed its Phase 3 enrolment target for Zilosul®, secured over A$21 million in capital, and pivots towards clinical evidence generation with major data readouts expected.

Syntara Limited’s FY2026 results show a 7.9% revenue decline and a 13.6% increase in net loss amid significant clinical progress, including FDA backing for its lead drug amsulostat and a successful $8.8 million capital raise.

Aeris Resources delivered a standout FY26 with revenues up 22% and profit after tax surging 295%, buoyed by operational gains and a strategic acquisition of Peel Mining.

Alliance Aviation Services has completed the institutional portion of its $40 million equity raise, securing $33 million to support its turnaround and debt reduction efforts. The retail entitlement offer opens in early September.

Credit Clear Limited posted a 28% rise in FY26 revenue to $60 million, boosted by UK acquisitions and organic growth, while defending legal action by the ACCC.

L1 Gold Fund Limited (ASX:LGF) has completed a major capital raising, securing A$254.9 million through institutional placement, entitlement, and shortfall offers. Founders Mark Landau and Raphael Lamm fully subscribed, underscoring confidence in the gold sector amid ongoing market volatility.

FireFly Metals has raised approximately A$190 million through institutional and bought deal placements, positioning the company to advance its Green Bay Copper-Gold Project with early works, drilling, and feasibility studies ahead of a mid-2027 investment decision.

GR Engineering Services secured $100 million through a heavily supported institutional placement priced at $6.10 per share, alongside a $10 million Share Purchase Plan for retail investors. The capital raise aims to bolster the balance sheet ahead of a busy contract delivery phase.

Acrux Limited reported a 46% revenue increase to $6.6 million in FY26, driven by US generic product royalties and licensing milestones, while narrowing its net loss by 90%. The company is pivoting towards developing a female testosterone therapy with encouraging Phase II data and active regulatory engagement.